Events

February 27-28, 2020. Washington DC. Inotrem will attend the 3CT Workshop (Critical Care Clinical Trialists) that will take place at the French Embassy on February 27th and 28th 2020 in Washington DC. During the 2-days Symposium, Inotrem will present the design of its ASTONISH Phase IIb clinical trial for Nangibotide

January 13-16, 2020. San Francisco. Inotrem will participate to the annual J.P. Morgan Healthcare Conference. It is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

December 3, 2019. Nancy. Cecile Jouclas, Inotrem’s Administrative and Financial Officer, will participate to the Deeptech Tour organized by the BPI. Cecile will be a host at the workshop “What tools to finance your deeptech project?” that will take place on the Université de Lorraine’s campus. Throughout France, the Deeptech

October 8-12 in Chania, Crete, Greece. Marc Derive, Co-founder and CSO of Inotrem, will present new preclinical data during the 18th ESS congress and 9th Congress of the IFSS, entitled “TREM-1 pharmacological inhibition by LR12/nangibotide improves survival and controls vascular leakage during experimental endotoxic shock in mice” in a session

28 September – 2 October 2019 in Berlin, Germany. European Society of Intensive Care Medicine’s (ESICM) annual congress attracts audiences of over 6,000 physicians, anesthetists, trainees and nursing and allied health professionals, every year, from every continent and 97 different countries. A diverse faculty of more than 300 international speakers

July 9. 2019 in Paris. Jean-Jacques Garaud, CEO at Inotrem, will be a speaker at the Solebury Trout Summer Investor tour, hosted by Andera Partners in Paris.

June 24. & June 25. 2019 in Paris. Inotrem will attend this exclusive event organized by France Biotech which brings together French and European HealthTech leaders, large pharmaceutical companies and international investors in health innovation.

June 17. 2019 in Paris (La Défense). Dr. Margarita Salcedo Magguilli, CDP at Inotrem, will be speaking at the roundtable “New regulatory paths to innovation” during the 3rd Biotech Meeting Day (Les Rencontres de la Biotech) organized by Pharmaceutiques.

May 5. 2019. Discover the interview of Jean-Jacques Garaud, CEO of Inotrem, laying out Inotrem’s recent milestones and internationalization strategy in PharmaBoardRoom.

February 19. 2019 in Paris. Martin Koch, COO of Inotrem, participates to “Market Access and Biotechnologies”, a panel discussion organized by France Biotech, France’s main non-profit organization which brings together the country’s leading innovative health companies and their expert partners. www.france-biotech.fr

January 23.-26. 2019 in Paris. Reanimation 2019 is the Annual congress organized by the French Intensive Care Society (www.srlf.org). Dr. Bruno François, Coordinating Physician at the CHU of Limoges, will present the MOT-C-201 Clinical Trial Results regarding safety and tolerability of nangibotide (LR12) in patients with septic shock. www.reanimation-lecongres.com

October 1-3, 2018 in Bangkok, Thailand The International Sepsis Forum (ISF) is an international collaboration to reduce the global burden of sepsis guided by prominent academics from around the world. Sepsis 2018 will be held as a joint meeting with the Thai Society of Critical Sepsis 2018 Medicine. http://internationalsepsisforum.com/